Pt 2/4

Covid can be Viral, Bacterial or Fungal

The chemical composition of each person varies which means their bodies respond to the 5G electromagnetic radiation in different ways.

Collective post link (all 4) :
https://t.me/EightQBall/208

https://t.me/EightQBall

Pt 3/4

Covid can be Viral, Bacterial or Fungal

The chemical composition of each person varies which means their bodies respond to the 5G electromagnetic radiation in different ways.

Collective post link (all 4) :
https://t.me/EightQBall/208

https://t.me/EightQBall

Pt 4/4

Covid can be Viral, Bacterial or Fungal

The chemical composition of each person varies which means their bodies respond to the 5G electromagnetic radiation in different ways.

Collective post link (all 4) :
https://t.me/EightQBall/208

https://t.me/EightQBall

COVID (or SARS) is the Specific Absorption Rate of EMF radiation. The "Severe Acute Respiratory Syndrome" is a way to mock us like they always do. Hiding in plain site

Stringer post link:
https://t.me/EightQBall/214

http://t.me/EightQBall

Release-17 which is 5G from satellites gets released on January 22. Save the date folks, shit will start hitting the fan right around then 👇👇👇👇

"If this continues then the vaccines will completely destroy the part of your immune system which deals with Covid by the end of January."

https://theexpose.uk/2021/10/15/its-worse-than-we-thought-fully-covid-vaccinated-ade/

Stringer post link:
https://t.me/EightQBall/213

Join: @EightQBall

I just took the dogs outside and saw this 👆A majority of the time, the work we do keeps our minds down in the depths because its the only way to expose the darkness and shine the light. But don't forget to look up so you don't miss the beauty and energy of the Universe.

Join:@EightQBall

every major "outbreak" was the result of a new technology producing electromagnetic radiation the human body had never experienced before. russian outbreak 77, russian woodpecker. weather satellite era, radar era, the modern flu with 3G and 4G and of course Covid from the 5G rollout

Stringer Post Links:
https://t.me/EightQBall/213
https://t.me/EightQBall/214 *


Join:@EightQBall

🔸 Judy Mikovitz: the 'covid' antidote
🔸100 yrs:WHO List of Essential medicines
🔸Suramin: $27 per dose:CDC Knows
🔸Reverses Autism, African Sleeping Sickness too
🔸Anti-Cancer, surpresses endothilial cell proliferation and agiogenesis

"You cannot push science and the development of new therapies beyond what is safe and smart, especially when the lives and well-being of children are involved. The cell danger response theory and the use of suramin as a remedy for it represent a profound paradigm shift in the culture of medicine and the treatment of many diseases".

Suramin is an anti-parasitic drug with apparent anti-cancer effects. It inhibits the signalling by many growth factors including VEGF and bFGF and suppresses endothelial cell proliferation and angiogenesis.
▪️https://health.ucsd.edu/news/topics/▪️Suramin-Autism/Pages/COVID-19-Response.aspx
▪️https://naviauxlab.ucsd.edu/
▪️https://en.wikipedia.org/wiki/Suramin
▪️https://www.sciencedirect.com/topics/neuroscience/suramin
🧐👀🤔
H/T: Hats
Join: @EightQBall

⭐️They will be able to control the jabbed
⭐️The nanoparticles in the jab get their energy to operate at 2.4 Ghz.
⭐️ This is the 5G range and frequency. No coincidences

"Moreover, by using a 2.4 GHz Wi-Fi source, we experimentally realize a prototype chemical sensor system that wirelessly harvests the energy varying from 0 mW up to 7 mW depending on the chemical concentration of the water-based binary mixtures"

Great catch, Paul!!!

Stringer Post Links:
https://t.me/EightQBall/216

join: https://t.me/EightQBall

⭐️Military, Federal Employees and Civil Contractors Sue Biden
⭐️ Liberty Counsel

ThanQ @RealGenFlynn

ThanQ, Gary

🇺🇸Class Action: For Military Friends & Families

https://lc.org/newsroom/details/101521-military-federal-employees-and-civilian-contractors-sue-biden

Join: https://t.me/EightQBall

⭐️ VERIFIED VAXX UPDATE ⭐️ STOP PRESS ⭐️

⭐️ All vaccines may no longer be justified from 20.10.2021⭐️

⭐️ The European Union has approved 5 therapies ⭐️

Vaccines were approved on a “temporary experimental basis”.

The regulation:
Once therapies or cures are authorised all experimental & emergency use authorisation STOPS!!!

Extract Translation:
Stella Kyriakides, Commissioner for Health and Food Safety, said: "Today we are taking the first step towards establishing a broad portfolio of COVID-19 treatments. Although vaccination is progressing at an increasing rate, the virus is not going away and patients will need safe and effective treatments to reduce the pressure of COVID-19. Our goal is clear: to identify other pioneering candidates under development and to authorize at least three new treatments by the end of the year. This is the European Health Union."


COVID-19 Treatment Strategy: Commission identifies five promising treatment candidates *

https://ec.europa.eu/commission/presscorner/detail/fr/ip_21_3299

Join: https://t.me/EightQBall

⭐️European Union/EMA Approving 5 Therapies
⭐️ October to End of 2021

ONCE APPROVED EUA IS NO LONGER: Pt 1/2

Doc./Original Post:
https://t.me/EightQBall/228

Translation:
Stella Kyriakides, Commissioner for Health and Food Safety, said: "Today we are taking the first step towards establishing a broad portfolio of COVID-19 treatments. Although vaccination is progressing at an increasing rate, the virus is not going away and patients will need safe and effective treatments to reduce the pressure of COVID-19. Our goal is clear: to identify other pioneering candidates under development and to authorize at least three new treatments by the end of the year. This is the European Health Union."
The five products are at an advanced stage of development and have a high chance of being among the three new treatments for COVID-19 that will be cleared by October 2021 — the goal set under the strategy — provided that the final data demonstrate their safety, quality and efficacy. These are the following products: a new COVID-19 indication for existing medicines:

a new COVID-19 indication for existing medicines: Eli Lilly's immunosuppressant baricitinib (a medicine that reduces the activity of the immune system): an application to extend the marketing authorisation to include the indication for COVID-19 is under consideration; newly developed monoclonal antibodies subject to continuous evaluation — a regulatory tool to accelerate the evaluation of a promising medicinal product in the event of a public health emergency:

Eli Lilly's combination of bamlanivimab and etesevimab: continuous evaluation; the combination of casirivimab and imdevimab from Regeneron Pharmaceuticals, Inc. and F. Hoffman-La Roche, Ltd: ongoing evaluation; Celltrion regdanvimab: continuous evaluation; GlaxoSmithKline's sotrovimab and Vir Biotechnology, Inc.: ongoing evaluation.

Timeline The Commission will develop by October a portfolio of at least 10 potential treatments for COVID-19, building on the work of the recently established Expert Group on COVID-19 Variants. The selection process will be objective and based on scientific data, with the selection criteria agreed with the Member States. Since different types of products are needed for different patient populations and different stages and degrees of disease severity, the expert group will establish product categories and select the most promising treatment candidates for each category, based on scientific criteria.

The portfolio will contribute to the goal of having at least three new treatments authorised by October and possibly two more by the end of the year. The European Medicines Agency will launch further ongoing evaluations of promising treatments by the end of 2021, based on research and development results.
The Commission has recently concluded a joint procurement agreement for the acquisition of monoclonal antibodies (casirivimab and imdevimab) and may launch further procedures by the end of the year. The first industry linking event regarding treatments will be held on July 12 and 13 to ensure that once authorized, treatments are produced in sufficient quantities, as quickly as possible.

Context The EU's COVID-19 Treatment Strategy aims to build a broad portfolio of COVID-19 treatments with the aim of having three new treatments available by October 2021 and possibly two more by the end of the year. It encompasses the entire life cycle of medicines, from research, development, selection of promising candidates, rapid regulatory approval, manufacture and deployment to their end use.

Pt 2/2

Context The strategy is part of the strengthening of a European Health Union, which is based on a coordinated EU approach to better protect the health of our citizens, with the aim of empowering the EU and its Member States to better prevent and respond to future pandemics and to improve the resilience of European health systems. This strategy, which focuses on the treatment of COVID-19 patients, is a continuation of the EU's proven Vaccine Strategy, in which the use of safe and effective COVID-19 vaccines has been authorised in the EU to prevent and reduce the transmission of cases, and rates of hospitalization and death caused by the disease.

Context Learn more Q&A: COVID-19 treatment strategy — list of 5 treatment candidates European Commission response to coronavirus: treatments EU Treatment Strategy European Medicines Agency — treatments for COVID-19 Updated on September 29, 2021 at 12:00 p.m.

The EU's COVID-19 treatment strategy is yielding a first result today, with the announcement of the first portfolio of five treatments that may soon be available to treat patients across the EU. Four of these treatments are monoclonal antibodies that are subject to continuous evaluation by the European Medicines Agency. The fifth is an immunosuppressant with a marketing authorization that could be extended to the treatment of covid-19 patients.

Pt 1/2 https://t.me/EightQBall/229